A case of paracoccidioidomycosis in the bilateral adrenal gland
DOI:
https://doi.org/10.53732/rccsalud/2023.e5207Keywords:
paracoccidioidomycosis, adrenal glands, invasive fungal infectionsAbstract
Paracoccidioidomycosis is an invasive fungal infection. Involvement of the adrenal gland is a rare form of presentation that is associated with up to 10 to 15% of suprarenal insufficiencies and sometimes it can be the first clinical manifestation of the pathology. The objective of the study is to describe an atypical presentation of a patient with a diagnosis of bilateral tumor of the suprarenal gland, that was suspected of a tumor process of the suprarenal glands and the definitive diagnosis with ultrasound-guided puncture biopsy was adrenal paracocciodioidomycosis. Treatment is carried out with amphotericin B at a dose of 50 mg/day up to a cumulative dose of 1500 mg, with subsequent follow-up with itraconazole of 200 to 400 mg/day for a period of 6 to 12 months.
References
Velázquez C, Lovera P. Paracoccidioidomicosis: Una Presentación Atípica. Rev Arg Med. 2022;10(1):61–4. http://www.revistasam.com.ar/index.php/RAM/article/view/691
Shikanai-Yasuda MA, Mendes RP, Colombo AL, Telles F de Q, Kono A, Paniago AMM, et al. II Consenso Brasileiro em Paracoccidioidomicose. Epidemiol Serv Saude. 2018 Aug 16;27(spe):e0500001. http://scielo.iec.gov.br/scielo.php?script=sci_arttext&pid=S1679-49742018000500002
de Almeida Jr JN, Peçanha PM, Colombo AL. Paracoccidioidomycosis in immunocompromised patients: A literature review. 2018;5(1):2. 10.3390/jof5010002
Araujo P, Aguilar G, Arce N, Martínez M. Paracoccidioidomicosis detectados en el período 2004-2013 en el Laboratorio Central de Salud Pública de Asunción - Paraguay. Rev. Nac. (Itauguá). 2016;8(2):62–71. http://scielo.iics.una.py/scielo.php?script=sci_arttext&pid=S2072-81742016000200062&lng=es&nrm=iso&tlng=es
Ribeiro SM, Nunes TF, de Souza Cavalcante R, Paniago AMM, Pereira BAS, Mendes RP. A scoping study of pulmonary paracoccidioidomycosis: severity classification based on radiographic and tomographic evaluation. J Venom Anim Toxins Incl Trop Dis. 2022;28e2020220053. 10.1590/1678-9199-JVATITD-2022-0053
Tejos L, Pérez Alfonzo R, Cavallera E, Oliver M. Paracoccidioidomicosis: Presentación inusual. Dermatología Venezolana. 2003;41(3):19-22. https://revista.svderma.org/index.php/ojs/article/view/287
Wagner G, Moertl D, Glechner A, Mayr V, Klerings I, Zachariah C, et al. Paracoccidioidomycosis diagnosed in europe—a systematic literature review. J Fungi (Basel). 2021;7(2):157. 10.3390/jof7020157
Pérez D, Oviedo J, Gill S. Paracoccidioidomicosis: características clínicas y evolutivas de 94 casos. RAMR. 2014;1:20-27. https://www.ramr.org/articulos/volumen_14_numero_1/articulos_originales/articulos_originales_paracoccidiodomicosis_caractericticas_clinicas.pdf
Sanabria CL, Alarcón ML, Alarcón IR, Jaimes MF. Paracoccidioidomicosis - Una enfermedad multisistémica. Acta Med Colomb. 2018; 43(2):111-114. http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0120-24482018000200111
Cermeño V JJ, Rosiris Cermeño J, Cova V MN, Pérez Modesta G. Función adrenocortical en pacientes con micosis sistémica. Invest Clin. 2007;48(3):341–8. https://www.redalyc.org/articulo.oa?id=372937668008
Thompson GR, Le T, Chindamporn A, Kauffman CA, Alastruey-Izquierdo A, Ampel NM, et al. Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology. Lancet Infect Dis. 2021;21(12): e364–e374. 10.1016/S1473-3099(21)00191-2
Recalde V, Oviedo J, Gill S y Pérez D. Paracoccidioidomicosis: Descripción de 113 casos. INERAM. 2005. https://www.neumoparaguay.org/files/pcm_113casos.pdf
Sousa JAB, Sá RS, Pereira EM. Consequences of late diagnosis paracoccidioidomycosis: Case report. J. Bras. Patol. Med. Lab. 2021;57(1). https://doi.org/10.5935/1676-2444.20210003
.png)
All the contents of this journal are licensed under a 